Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Uterine Cervical Neoplasms × erdafitinib × Clear all

Sponsor

Conditions

Wilms Tumor 2 Urothelial Cancer 2 Rhabdoid Tumor 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neuroblastoma 2 Medulloblastoma 2 Lymphoma, Non-Hodgkin 2 Histiocytosis, Langerhans-Cell 2 Hepatoblastoma 2 Glioma 2 Ependymoma 2 Central Nervous System Neoplasms 2 Xanthogranuloma, Juvenile 1 Urinary Bladder Neoplasms 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Prostatic Neoplasms 1 Osteosarcoma 1 Non-Muscle Invasive Bladder Neoplasms 1 Multiple Myeloma 1 Malignant Solid Neoplasm 1 Lymphoma 1 Histiocytic Sarcoma 1 Familial ependymoma 1 Carcinoma, Transitional Cell 1 Breast Neoplasms 1 Advanced Solid Tumor 1

Interventions

Cisplatin 32 human papillomavirus vaccine, L1 type 16, 18 16 Brachytherapy 15 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 12 Paclitaxel 11 Bevacizumab 11 pembrolizumab 9 Platinum 9 1,2-diaminocyclohexaneplatinum II citrate 9 Topotecan 8 Radiotherapy, Intensity-Modulated 8 Radiation 8 Papillomavirus Vaccines 8 atezolizumab 6 Gemcitabine 6 Fluorodeoxyglucose F18 6 Cyclophosphamide 6 tisotumab vedotin 5 fludarabine phosphate 5 fludarabine 5 aldesleukin 5 Taxes 5 Radiotherapy 5 Magnetic Resonance Spectroscopy 5 Carboplatin 5 Vaccines, Synthetic 4 Nivolumab 4 Immunoglobulin G 4 Disulfides 4 Colposcopy 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡